Reply to Carlos G. Wambier and Gerard J. Nau's Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-93. Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients: Still No Positive Effect of Enzalutamide for Hospitalized COVID-19 Patients.

Welén K, Rosendal E, Freyhult E, Oh WK, Gisslén M, Ahlm C, Connolly AF, Överby AK, Josefsson A

Eur. Urol. 81 (6) e143-e144 [2022-06-00; online 2022-02-23]

Bioinformatics Support and Infrastructure [Collaborative]

Bioinformatics Support, Infrastructure and Training [Collaborative]

PubMed 35248411

DOI 10.1016/j.eururo.2022.02.016

Crossref 10.1016/j.eururo.2022.02.016

pmc: PMC8864103
pii: S0302-2838(22)01659-1

Publications 9.5.0